http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721150-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate 2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104721150-B
titleOfInvention A kind of pharmaceutical composition comprising olaquindox and preparation method thereof
abstract The present invention relates to a kind of pharmaceutical composition comprising olaquindox and preparation method thereof.Count, the pharmaceutical composition for including olaquindox of the invention, formed comprising or by following component in parts by weight:5~55 parts of olaquindox, 45~95 parts of embedding medium.Olaquindox micro-capsule provided by the invention, solves the cross pollution of the feed preparation caused by Electrostatic Absorption of traditional olaquindox pulvis.The olaquindox of the present invention with embedding medium is combined by molecular state, the sustained-release matrix property of embedding medium, makes olaquindox extended durations of action, and blood concentration is stable, reduces times for spraying, reduces raiser's drug cost, increases economic efficiency.Clinical test proves that olaquindox micro-capsule product effect provided by the invention is common three times of olaquindox powder product.
priorityDate 2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0707798-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16108993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420562544
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID749906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID749906
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413232186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71905
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21103107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419622089

Total number of triples: 39.